Veteran Pharma Executive Myrtle Potter Joins Keynote Faculty of the 25th Pharmaceutical & Medical Device Ethics and Compliance Congress
  • A Hybrid Onsite Conference and Internet Event
  • The Leading Forum on Pharmaceutical and Medical Device Ethics and Compliance Issues
  • Sponsored by Pharmaceutical Compliance Forum
  • Media Partner: Policy & Medicine
  • October 28-30, 2024
  • Grand Hyatt Washington
  • Washington, DC
  • www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com
JOIN US TO CELEBRATE 25 YEARS OF COLLABORATION AMONG INDUSTRY, GOVERNMENT AND INDUSTRY PARTNERS TO PROMOTE ETHICS AND COMPLIANCE IN THE PHARMACEUTICAL AND MEDICAL DEVICE INDUSTRIES

FOR THE FIRST TIME ALL ONSITE ATTENDEES WILL ALSO HAVE ACCESS TO THE CONGRESS LIVE AND ARCHIVED VIRTUAL BROADCAST
FEATURING KEYNOTE ADDRESS BY


Myrtle Potter
Board, Liberty Mutual, Guardant Health, Opentrons & U of Chicago; Former President and CEO, Sumitomo Pharma America & Chair, Sumitomo Pharma UK; Former CEO, Sumitovant Biopharma; Former Vant Operating Chair, Roivant; Former President, Commercial Operations, Genentech; Former President, Cardiovascular/Metabolics, BMS, Cambridge, MA

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- APRIL 3, 2024: We are pleased to announce that the Twenty-Fifth Pharmaceutical & Medical Device Ethics and Compliance Congress sponsored by the Pharmaceutical Compliance Forum (PCF) will be held at the Grand Hyatt Washington, Washington, DC on October 28-30, 2024. Attendees may attend either virtually online or in person. For the first time, onsite attendees will also enjoy both live and post-conference access to the Congress audio/video archive.

KEYNOTE SPEAKERS

Regina Barzilay, PhD
School of Engineering Distinguished Professor for AI and Health, MIT Center for Machine Learning in Health; AI Faculty Lead, Jameel Clinic, MIT Computer Science & Artificial Intelligence Lab; Recipient, MacArthur Fellowship, NSF Career Award, and AAAI Squirrel AI Award for Artificial Intelligence for the Benefit of Humanity, Cambridge, MA
Myrtle Potter
Board, Liberty Mutual, Guardant Health, Opentrons & U of Chicago; Former President and CEO, Sumitomo Pharma America & Chair, Sumitomo Pharma UK; Former CEO, Sumitovant Biopharma; Former Vant Operating Chair, Roivant; Former President, Commercial Operations, Genentech; Former President, Cardiovascular/Metabolics, BMS, Cambridge, MA
Brent Saunders, MBA, JD
Chairman & Chief Executive Officer, Bausch + Lomb; Former Chair, President & CEO, Allergan; President & CEO, Actavis plc; President & CEO, Forest Laboratories; President, Global Consumer Healthcare; Schering-Plough; Co-founder, International Association of Privacy Professionals (IAPP) and Pharmaceutical Compliance Forum (PCF), Miami Beach, FL

ANNUAL UPDATES FROM AdvaMed, PhRMA AND BIO

John Delacourt, JD
Deputy General Counsel, Biotechnology Innovation Organization; Former Chief Antitrust Counsel, Office of Policy Planning, Federal Trade Commission, Washington, DC
Ida Nassar, JD
Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, Drug Enforcement Administration, Washington, DC
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC

EARLY BIRD REGISTRATION DISCOUNT
Click here for discounted registration.
LARGE GROUP REGISTRATION DISCOUNTS AVAILABLE
Click here for group registration discounts.
PRESENTATION PROPOSALS
Click here to submit a presentation proposal.
SPONSORED BY
PRODUCED BY
MEDIA PARTNERS




FEATURED FACULTY

Adriana Davies, JSM
Vice President, Compliance & Data Privacy, US Office of Ethics & Compliance, Smith & Nephew; Former Senior Compliance Director MITG, Medtronic Medical Surgical, Jacksonville, FL
Sarah diFrancesca, JD
Executive Director Compliance, Dermatology, Incyte, Chadds Ford, PA
Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Chief Compliance Officer, Purdue Pharma LP; Former Co-chair, PCF, Stamford, CT

Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda; Former Compliance Head, Rare Disease and Rare Blood Disorders, Sanofi, Boston, MA
Christine Gordon, JD
Chief Compliance Officer & Head of GRC; Governance, Risk & Compliance Function, Olympus Corporation of the Americas; Former Assistant District Attorney, Philadelphia District Attorney's Office, Bethlehem, PA
Michael G. Hercz, JD
Senior Vice President and General Counsel, Sentyn; Former Executive Director, Enterprise Risk Management, Amgen, Los Angeles, CA

Rim El Kassaby, LLM
Director US Business Counseling and Support, Organon, Dubai, UAE
Terri L. Ledva, MS
Director, Ethics and Compliance, Aurobindo Pharma LTD; Former Senior Manager Compliance, Iroko Pharmaceuticals LLC, Philadelphia, PA
Gregory S. Moss, JD
Chief Corporate Strategy & Legal Officer, Evomunne; Former Executive Vice President, General Counsel and Corporate Secretary, Chief Compliance Officer, Kadmon Holdings, Palo Alta, CA

PCF BOARD

Donna White, CCEP
Vice President and Compliance Officer, Chiesi (Board Chair)
Christie Camelio
Senior Vice President and Chief Compliance Officer, Insmed (Board Secretary)
Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte (Board Treasurer)

Cindy Cetani, LPEC, NACD.DC®
Chief Integrity and Compliance Officer, Indivior
Anisa Dhalla
Vice President and Chief Ethics and Compliance Officer, UCB
Daryl Kreml, JD
Senior Vice President, Chief Enterprise Risk and Compliance Officer, Sage Therapeutics

MEDICAL DEVICE EXECUTIVE COMMITTEE

Michael R. Clarke, JD, CCEP
VP, Global CCO, ConvaTec
Sujata Dayal, JD
Independent Board Director, Emergent; BioSolutions; Senior Advisor, Ethicist International

Tara Shewchuk, JD
Global Chief Ethics & Compliance Officer, Medtronic
Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker

CONGRESS REGISTRATION
For Congress registration information, visit https://www.pharmacongress.com/registration-splash/, email reginfo@hcconferences.com, or call 800-503-7419.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information contact Sarah Grosse, Exhibit & Sponsorship Coordinator, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.

FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.